A cross-functional Project Manager by training, Sam trained and served in Head Project Manager roles at various CDMOs before joining DHC.
CMC
Samantha Conner is a seasoned project management professional and Principal at Dark Horse Consulting, where she leads cross-functional initiatives supporting cutting-edge CGT programs. With over a decade of experience spanning CDMO environments and pharmaceutical startups, she brings a unique blend of technical insight, strategic execution, and client-focused leadership to every engagement.
Samantha began her career at Cytovance Biologics in 2010, where she built a strong foundation in biologics within a CDMO setting. She continued to grow her expertise at Paragon Bioservices (later Catalent), deepening her involvement in CGT. In 2020, Samantha transitioned into the startup space with Deka Biosciences, gaining valuable Sponsor-side perspective and experience in navigating the dynamic landscape of early-phase drug development.
Her career has been defined by the ability to manage complex, cross-disciplinary projects across diverse therapeutic platforms. Known for her clear communication, organization ability and results-driven mindset, Samantha thrives in collaborative environments that demand both strategic oversight and hands-on problem solving and is recognized for her ability to bridge technical and operational disciplines to deliver successful outcomes
Today, Sam partners with clients to provide expert project management for high-stakes CGT programs: bringing the rare combination of CDMO and Sponsor experience that adds clarity, momentum, and value for early development through delivery.
Samantha holds a Bachelor of Science in Biological Sciences from the University of Texas, El Paso.
Samantha Conner is a seasoned project management professional and Principal at Dark Horse Consulting, where she leads cross-functional initiatives supporting cutting-edge CGT programs. With over a decade of experience spanning CDMO environments and pharmaceutical startups, she brings a unique blend of technical insight, strategic execution, and client-focused leadership to every engagement.
Samantha began her career at Cytovance Biologics in 2010, where she built a strong foundation in biologics within a CDMO setting. She continued to grow her expertise at Paragon Bioservices (later Catalent), deepening her involvement in CGT. In 2020, Samantha transitioned into the startup space with Deka Biosciences, gaining valuable Sponsor-side perspective and experience in navigating the dynamic landscape of early-phase drug development.
Her career has been defined by the ability to manage complex, cross-disciplinary projects across diverse therapeutic platforms. Known for her clear communication, organization ability and results-driven mindset, Samantha thrives in collaborative environments that demand both strategic oversight and hands-on problem solving and is recognized for her ability to bridge technical and operational disciplines to deliver successful outcomes
Today, Sam partners with clients to provide expert project management for high-stakes CGT programs: bringing the rare combination of CDMO and Sponsor experience that adds clarity, momentum, and value for early development through delivery.
Samantha holds a Bachelor of Science in Biological Sciences from the University of Texas, El Paso.